Exaggeration of treatment benefits using the "event-based" number needed to treat.
作者信息
Aaron Shawn D, Fergusson Dean A
机构信息
Ottawa Health Research Institute, University of Ottawa, Ottawa, Ont.
出版信息
CMAJ. 2008 Sep 23;179(7):669-71. doi: 10.1503/cmaj.080018.
Abstract
摘要
相似文献
1
Exaggeration of treatment benefits using the "event-based" number needed to treat.
CMAJ. 2008 Sep 23;179(7):669-71. doi: 10.1503/cmaj.080018.
2
[Number needed to treat: definition, interpretation and relevance].
Gesundheitswesen. 2009 Oct;71(10):694-9; quiz 700-1. doi: 10.1055/s-0029-1220382. Epub 2009 Nov 2.
3
[Number needed to treat (NNT)-- misleading, misunderstood, misused?].
Tidsskr Nor Laegeforen. 2004 Aug 12;124(15):1926-9.
4
[Number needed to treat: a useful tool for estimating the effectiveness of a treatment].
Tijdschr Psychiatr. 2008;50(6):337-43.
5
Methodological considerations, such as directed acyclic graphs, for studying "acute on chronic" disease epidemiology: chronic obstructive pulmonary disease example.
J Clin Epidemiol. 2009 Sep;62(9):982-90. doi: 10.1016/j.jclinepi.2008.10.005. Epub 2009 Feb 10.
6
Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat.
CMAJ. 2004 Aug 17;171(4):353-8. doi: 10.1503/cmaj.1021197.
7
Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Pharmacotherapy. 2009 Sep;29(9):1039-53. doi: 10.1592/phco.29.9.1039.
8
Use of spirometry in the diagnosis of chronic obstructive pulmonary disease and efforts to improve quality of care.
Transl Res. 2009 Sep;154(3):103-10. doi: 10.1016/j.trsl.2009.06.003. Epub 2009 Jul 8.
9
Safety reporting in randomized clinical trials - a need for improvement.
Bull NYU Hosp Jt Dis. 2009;67(2):209-10.
10
Chronic kidney disease in Japan from early predictions to current facts.
Nephron Clin Pract. 2008;110(4):c268-72. doi: 10.1159/000170094. Epub 2008 Nov 10.
引用本文的文献
1
Dexamethasone in Patients Hospitalized with COVID-19: Whether, When and to Whom.
J Clin Med. 2021 Apr 10;10(8):1607. doi: 10.3390/jcm10081607.
2
From Clinical Trial Efficacy to Real-Life Effectiveness: Why Conventional Metrics do not Work.
Drugs Real World Outcomes. 2019 Sep;6(3):125-132. doi: 10.1007/s40801-019-0159-z.
3
Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
Respir Res. 2019 May 27;20(1):104. doi: 10.1186/s12931-019-1078-y.
4
Number Needed to Treat in Multiple Sclerosis Clinical Trials.
Neurol Ther. 2017 Jun;6(1):1-9. doi: 10.1007/s40120-017-0063-y. Epub 2017 Feb 7.
本文引用的文献
1
A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease.
Thorax. 2008 Mar;63(3):194-200. doi: 10.1136/thx.2007.077578. Epub 2007 Sep 27.
2
Avoiding mistakes in calculating the number needed to treat in severe COPD.
Am J Respir Crit Care Med. 2007 Jun 15;175(12):1347; author reply 1347-8. doi: 10.1164/ajrccm.175.12.1347a.
3
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.
N Engl J Med. 2007 Feb 22;356(8):775-89. doi: 10.1056/NEJMoa063070.
4
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2007 Jan 15;175(2):144-9. doi: 10.1164/rccm.200602-244OC. Epub 2006 Oct 19.
5
Application of Number Needed to Treat (NNT) as a Measure of Treatment Effect in Respiratory Medicine.
Treat Respir Med. 2006;5(2):79-84. doi: 10.2165/00151829-200605020-00001.
6
Evaluating the effectiveness of combination therapy to prevent COPD exacerbations: the value of NNT analysis.
Int J Clin Pract. 2005 Oct;59(10):1187-94. doi: 10.1111/j.1368-5031.2005.00664.x.
7
Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.
Arch Neurol. 2004 Jul;61(7):1066-70. doi: 10.1001/archneur.61.7.1066.
8
Number needed to treat (NNT): estimation of a measure of clinical benefit.
Stat Med. 2001 Dec 30;20(24):3947-62. doi: 10.1002/sim.1173.
9
Confidence intervals for the number needed to treat.
BMJ. 1998 Nov 7;317(7168):1309-12. doi: 10.1136/bmj.317.7168.1309.
10
The number needed to treat: a clinically useful measure of treatment effect.
BMJ. 1995 Feb 18;310(6977):452-4. doi: 10.1136/bmj.310.6977.452.
Zotero 插件